{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:36:03Z","timestamp":1791326163030,"version":"4.3.1"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A microfluidic multi-organ chip emulates the tissue culture microenvironment, enables interconnection of organ equivalents and overcomes interspecies differences, making this technology a promising and powerful tool for preclinical drug screening. In this study, we established a microfluidic chip-based model that enabled non-contact cocultivation of liver spheroids and renal proximal tubule barriers in a connecting media circuit over 16 days. Meanwhile, a 14-day repeated-dose systemic administration of cyclosporine A (CsA) alone or in combination with rifampicin was performed. Toxicity profiles of the two different doses of CsA on different target organs could be discriminated and that concomitant treatment with rifampicin from day6 onwards decreased the CsA concentration and attenuated the toxicity compared with that after treatment with CsA for 14 consecutive days. The latter is manifested with the changes in cytotoxicity, cell viability and apoptosis, gene expression of metabolic enzymes and transporters, and noninvasive toxicity biomarkers. The on chip coculture of the liver and the proximal tubulus equivalents showed its potential as an effective and translational tool for repeated dose multi-drug toxicity screening in the preclinical stage of drug development.<\/jats:p>","DOI":"10.1038\/s41598-020-65817-0","type":"journal-article","created":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T10:03:14Z","timestamp":1591005794000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Repeated dose multi-drug testing using a microfluidic chip-based coculture of human liver and kidney proximal tubules equivalents"],"prefix":"10.1038","volume":"10","author":[{"given":"Ni","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingchao","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Drewell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane","family":"H\u00fcbner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuogang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Marx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,1]]},"reference":[{"key":"65817_CR1","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s11096-018-0719-4","volume":"40","author":"LG Martin","year":"2018","unstructured":"Martin, L. G., Hanssens, Y. & Paudyal, V. Overview of this issue: pharmacovigilance, what is new? International journal of clinical pharmacy 40, 737\u2013739, https:\/\/doi.org\/10.1007\/s11096-018-0719-4 (2018).","journal-title":"International journal of clinical pharmacy"},{"key":"65817_CR2","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1081\/dmr-120034148","volume":"36","author":"B Gunawan","year":"2004","unstructured":"Gunawan, B. & Kaplowitz, N. Clinical perspectives on xenobiotic-induced hepatotoxicity. Drug metabolism reviews 36, 301\u2013312, https:\/\/doi.org\/10.1081\/dmr-120034148 (2004).","journal-title":"Drug metabolism reviews"},{"key":"65817_CR3","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/372801a0","volume":"372","author":"F Lafont","year":"1994","unstructured":"Lafont, F., Burkhardt, J. K. & Simons, K. Involvement of microtubule motors in basolateral and apical transport in kidney cells. Nature 372, 801\u2013803 (1994).","journal-title":"Nature"},{"key":"65817_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1039\/c2tx20051a","volume":"2","author":"VY Soldatow","year":"2013","unstructured":"Soldatow, V. Y., Lecluyse, E. L., Griffith, L. G. & Rusyn, I. In vitro models for liver toxicity testing. Toxicology research 2, 23\u201339, https:\/\/doi.org\/10.1039\/c2tx20051a (2013).","journal-title":"Toxicology research"},{"key":"65817_CR5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1089\/aivt.2016.0003","volume":"2","author":"MS Hutson","year":"2016","unstructured":"Hutson, M. S. et al. Organs-on-Chips as Bridges for Predictive Toxicology. Applied In Vitro Toxicology 2, 97\u2013102 (2016).","journal-title":"Applied In Vitro Toxicology"},{"key":"65817_CR6","first-page":"198","volume":"54","author":"N Burden","year":"2015","unstructured":"Burden, N., Chapman, K., Sewell, F. & Robinson, V. Pioneering better science through the 3Rs: an introduction to the national centre for the replacement, refinement, and reduction of animals in research (NC3Rs). Journal of the American Association for Laboratory Animal Science: JAALAS 54, 198\u2013208 (2015).","journal-title":"Journal of the American Association for Laboratory Animal Science: JAALAS"},{"key":"65817_CR7","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1093\/toxsci\/kfu234","volume":"143","author":"TB Knudsen","year":"2015","unstructured":"Knudsen, T. B. et al. FutureTox II: in vitro data and in silico models for predictive toxicology. Toxicological sciences: an official journal of the Society of Toxicology 143, 256\u2013267, https:\/\/doi.org\/10.1093\/toxsci\/kfu234 (2015).","journal-title":"Toxicological sciences: an official journal of the Society of Toxicology"},{"key":"65817_CR8","doi-asserted-by":"publisher","unstructured":"Materne, E. M. et al. The multi-organ chip\u2013a microfluidic platform for long-term multi-tissue coculture. Journal of visualized experiments: JoVE, e52526, https:\/\/doi.org\/10.3791\/52526 (2015).","DOI":"10.3791\/52526"},{"key":"65817_CR9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.14573\/altex.1710181","volume":"35","author":"PF Secker","year":"2018","unstructured":"Secker, P. F., Luks, L., Schlichenmaier, N. & Dietrich, D. R. RPTEC\/TERT1 cells form highly differentiated tubules when cultured in a 3D matrix. Altex 35, 223\u2013234, https:\/\/doi.org\/10.14573\/altex.1710181 (2018).","journal-title":"Altex"},{"key":"65817_CR10","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.tiv.2014.12.003","volume":"30","author":"L Aschauer","year":"2015","unstructured":"Aschauer, L., Carta, G., Vogelsang, N., Schlatter, E. & Jennings, P. Expression of xenobiotic transporters in the human renal proximal tubule cell line RPTEC\/TERT1. Toxicology in Vitro 30, 95\u2013105, https:\/\/doi.org\/10.1016\/j.tiv.2014.12.003 (2015).","journal-title":"Toxicology in Vitro"},{"key":"65817_CR11","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1039\/c5lc00392j","volume":"15","author":"I Maschmeyer","year":"2015","unstructured":"Maschmeyer, I. et al. A four-organ-chip for interconnected long-term co-culture of human intestine, liver, skin and kidney equivalents. Lab Chip 15, 2688\u20132699, https:\/\/doi.org\/10.1039\/c5lc00392j (2015).","journal-title":"Lab Chip"},{"key":"65817_CR12","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/FTD.0b013e3181e44244","volume":"32","author":"DA Hesselink","year":"2010","unstructured":"Hesselink, D. A., Bouamar, R. & van Gelder, T. The pharmacogenetics of calcineurin inhibitor-related nephrotoxicity. Therapeutic drug monitoring 32, 387\u2013393, https:\/\/doi.org\/10.1097\/FTD.0b013e3181e44244 (2010).","journal-title":"Therapeutic drug monitoring"},{"key":"65817_CR13","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3949\/ccjm.61.4.308","volume":"61","author":"RM Graham","year":"1994","unstructured":"Graham, R. M. Cyclosporine: mechanisms of action and toxicity. Cleveland Clinic journal of medicine 61, 308\u2013313 (1994).","journal-title":"Cleveland Clinic journal of medicine"},{"key":"65817_CR14","doi-asserted-by":"publisher","first-page":"819","DOI":"10.2165\/00003088-200342090-00003","volume":"42","author":"M Niemi","year":"2003","unstructured":"Niemi, M., Backman, J. T., Fromm, M. F., Neuvonen, P. J. & Kivist\u00f6, K. T. Pharmacokinetic Interactions with Rifampicin. Clinical Pharmacokinetics 42, 819\u2013850, https:\/\/doi.org\/10.2165\/00003088-200342090-00003 (2003).","journal-title":"Clinical Pharmacokinetics"},{"key":"65817_CR15","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.phrs.2007.07.010","volume":"56","author":"D Cibulskyte","year":"2007","unstructured":"Cibulskyte, D., Pedersen, M., Jakobsen, P., Hansen, H. E. & Mortensen, J. Pharmacokinetic characterization of a pig model of ciclosporin A nephrotoxicity following intravenous administration. Pharmacological research 56, 311\u2013317, https:\/\/doi.org\/10.1016\/j.phrs.2007.07.010 (2007).","journal-title":"Pharmacological research"},{"key":"65817_CR16","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.tiv.2014.12.016","volume":"29","author":"WF Van den Hof","year":"2015","unstructured":"Van den Hof, W. F. et al. Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro. Toxicology in vitro: an international journal published in association with BIBRA 29, 489\u2013501, https:\/\/doi.org\/10.1016\/j.tiv.2014.12.016 (2015).","journal-title":"Toxicology in vitro: an international journal published in association with BIBRA"},{"key":"65817_CR17","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jprot.2012.11.022","volume":"79","author":"A Wilmes","year":"2013","unstructured":"Wilmes, A. et al. Application of integrated transcriptomic, proteomic and metabolomic profiling for the delineation of mechanisms of drug induced cell stress. J Proteomics 79, 180\u2013194, https:\/\/doi.org\/10.1016\/j.jprot.2012.11.022 (2013).","journal-title":"J Proteomics"},{"key":"65817_CR18","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.tiv.2015.07.016","volume":"30","author":"P Bellwon","year":"2015","unstructured":"Bellwon, P. et al. Kinetics and dynamics of cyclosporine A in three hepatic cell culture systems. Toxicology in vitro: an international journal published in association with BIBRA 30, 62\u201378, https:\/\/doi.org\/10.1016\/j.tiv.2015.07.016 (2015).","journal-title":"Toxicology in vitro: an international journal published in association with BIBRA"},{"key":"65817_CR19","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/0002-9343(84)90356-5","volume":"77","author":"AG Palestine","year":"1984","unstructured":"Palestine, A. G., Nussenblatt, R. B. & Chan, C.-C. Side effects of systemic cyclosporine in patients not undergoing transplantation. The American Journal of Medicine 77, 652\u2013656, https:\/\/doi.org\/10.1016\/0002-9343(84)90356-5 (1984).","journal-title":"The American Journal of Medicine"},{"key":"65817_CR20","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/clpt.1992.171","volume":"52","author":"MF Hebert","year":"1992","unstructured":"Hebert, M. F., Roberts, J. P., Prueksaritanont, T. & Benet, L. Z. Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme induction. Clinical pharmacology and therapeutics 52, 453\u2013457 (1992).","journal-title":"Clinical pharmacology and therapeutics"},{"key":"65817_CR21","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nbt.1625","volume":"28","author":"F Dieterle","year":"2010","unstructured":"Dieterle, F. et al. Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium. Nature biotechnology 28, 455\u2013462, https:\/\/doi.org\/10.1038\/nbt.1625 (2010).","journal-title":"Nature biotechnology"},{"key":"65817_CR22","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.bios.2016.07.015","volume":"86","author":"S Cho","year":"2016","unstructured":"Cho, S., Islas-Robles, A., Nicolini, A. M., Monks, T. J. & Yoon, J. Y. In situ, dual-mode monitoring of organ-on-a-chip with smartphone-based fluorescence microscope. Biosensors & bioelectronics 86, 697\u2013705, https:\/\/doi.org\/10.1016\/j.bios.2016.07.015 (2016).","journal-title":"Biosensors & bioelectronics"},{"key":"65817_CR23","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.addr.2013.12.011","volume":"69-70","author":"C Giese","year":"2014","unstructured":"Giese, C. & Marx, U. Human immunity in vitro - solving immunogenicity and more. Advanced drug delivery reviews 69-70, 103\u2013122, https:\/\/doi.org\/10.1016\/j.addr.2013.12.011 (2014).","journal-title":"Advanced drug delivery reviews"},{"key":"65817_CR24","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1039\/c3lc50234a","volume":"13","author":"I Wagner","year":"2013","unstructured":"Wagner, I. et al. A dynamic multi-organ-chip for long-term cultivation and substance testing proven by 3D human liver and skin tissue co-culture. Lab Chip 13, 3538\u20133547, https:\/\/doi.org\/10.1039\/c3lc50234a (2013).","journal-title":"Lab Chip"},{"key":"65817_CR25","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1002\/term.2507","volume":"12","author":"S Sieber","year":"2018","unstructured":"Sieber, S. et al. Bone marrow-on-a-chip: Long-term culture of human haematopoietic stem cells in a three-dimensional microfluidic environment. Journal of tissue engineering and regenerative medicine 12, 479\u2013489, https:\/\/doi.org\/10.1002\/term.2507 (2018).","journal-title":"Journal of tissue engineering and regenerative medicine"},{"key":"65817_CR26","doi-asserted-by":"publisher","unstructured":"Mathur, A. et al. Human induced pluripotent stem cell-based microphysiological tissue models of myocardium and liver for drug development. Stem Cell Res Ther 4 Suppl 1, S14, https:\/\/doi.org\/10.1186\/scrt375 (2013).","DOI":"10.1186\/scrt375"},{"key":"65817_CR27","doi-asserted-by":"publisher","first-page":"025001","DOI":"10.1088\/1658-5090\/aaf9fa","volume":"11","author":"H Lee","year":"2019","unstructured":"Lee, H. et al. Cell-printed 3D liver-on-a-chip possessing a liver microenvironment and biliary system. Biofabrication 11, 025001, https:\/\/doi.org\/10.1088\/1658-5090\/aaf9fa (2019).","journal-title":"Biofabrication"},{"key":"65817_CR28","doi-asserted-by":"publisher","unstructured":"Corrado, B., De Gregorio, V. & Imparato, G. A three-dimensional microfluidized liver system to assess hepatic drug metabolism and hepatotoxicity. https:\/\/doi.org\/10.1002\/bit.26902 (2018).","DOI":"10.1002\/bit.26902"},{"key":"65817_CR29","doi-asserted-by":"publisher","first-page":"015014","DOI":"10.1088\/1758-5090\/9\/1\/015014","volume":"9","author":"AA Banaeiyan","year":"2017","unstructured":"Banaeiyan, A. A. et al. Design and fabrication of a scalable liver-lobule-on-a-chip microphysiological platform. Biofabrication 9, 015014, https:\/\/doi.org\/10.1088\/1758-5090\/9\/1\/015014 (2017).","journal-title":"Biofabrication"},{"key":"65817_CR30","doi-asserted-by":"publisher","unstructured":"Yu, F. et al. A perfusion incubator liver chip for 3D cell culture with application on chronic hepatotoxicity testing. 7, 14528, https:\/\/doi.org\/10.1038\/s41598-017-13848-5 (2017).","DOI":"10.1038\/s41598-017-13848-5"},{"key":"65817_CR31","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1039\/c3lc50240f","volume":"13","author":"EM Materne","year":"2013","unstructured":"Materne, E. M., Tonevitsky, A. G. & Marx, U. Chip-based liver equivalents for toxicity testing\u2013organotypicalness versus cost-efficient high throughput. Lab Chip 13, 3481\u20133495, https:\/\/doi.org\/10.1039\/c3lc50240f (2013).","journal-title":"Lab Chip"},{"key":"65817_CR32","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jbiotec.2015.02.002","volume":"205","author":"EM Materne","year":"2015","unstructured":"Materne, E. M. et al. A multi-organ chip co-culture of neurospheres and liver equivalents for long-term substance testing. Journal of biotechnology 205, 36\u201346, https:\/\/doi.org\/10.1016\/j.jbiotec.2015.02.002 (2015).","journal-title":"Journal of biotechnology"},{"key":"65817_CR33","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ejpb.2015.03.002","volume":"95","author":"I Maschmeyer","year":"2015","unstructured":"Maschmeyer, I. et al. Chip-based human liver-intestine and liver-skin co-cultures\u2013A first step toward systemic repeated dose substance testing in vitro. European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 95, 77\u201387, https:\/\/doi.org\/10.1016\/j.ejpb.2015.03.002 (2015).","journal-title":"European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V"},{"key":"65817_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-14815-w","volume":"7","author":"S Bauer","year":"2017","unstructured":"Bauer, S. et al. Functional coupling of human pancreatic islets and liver spheroids on-a-chip: Towards a novel human ex vivo type 2 diabetes model. Scientific reports 7, 14620, https:\/\/doi.org\/10.1038\/s41598-017-14815-w (2017).","journal-title":"Scientific reports"},{"key":"65817_CR35","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/j.tiv.2014.08.004","volume":"28","author":"A Ferreira","year":"2014","unstructured":"Ferreira, A., Rodrigues, M., Silvestre, S., Falcao, A. & Alves, G. HepaRG cell line as an in vitro model for screening drug-drug interactions mediated by metabolic induction: amiodarone used as a model substance. Toxicology in vitro: an international journal published in association with BIBRA 28, 1531\u20131535, https:\/\/doi.org\/10.1016\/j.tiv.2014.08.004 (2014).","journal-title":"Toxicology in vitro: an international journal published in association with BIBRA"},{"key":"65817_CR36","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.vascn.2010.04.013","volume":"63","author":"M Lubberstedt","year":"2011","unstructured":"Lubberstedt, M. et al. HepaRG human hepatic cell line utility as a surrogate for primary human hepatocytes in drug metabolism assessment in vitro. Journal of pharmacological and toxicological methods 63, 59\u201368, https:\/\/doi.org\/10.1016\/j.vascn.2010.04.013 (2011).","journal-title":"Journal of pharmacological and toxicological methods"},{"key":"65817_CR37","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10565-016-9316-2","volume":"32","author":"Y Wu","year":"2016","unstructured":"Wu, Y. et al. The HepaRG cell line, a superior in vitro model to L-02, HepG2 and hiHeps cell lines for assessing drug-induced liver injury. Cell biology and toxicology 32, 37\u201359, https:\/\/doi.org\/10.1007\/s10565-016-9316-2 (2016).","journal-title":"Cell biology and toxicology"},{"key":"65817_CR38","doi-asserted-by":"publisher","first-page":"272","DOI":"10.14573\/altex.1603161","volume":"33","author":"U Marx","year":"2016","unstructured":"Marx, U. et al. Biology-inspired microphysiological system approaches to solve the prediction dilemma of substance testing. Altex 33, 272\u2013321, https:\/\/doi.org\/10.14573\/altex.1603161 (2016).","journal-title":"Altex"},{"key":"65817_CR39","doi-asserted-by":"publisher","first-page":"C1053","DOI":"10.1152\/ajpcell.00331.2012","volume":"304","author":"A Dash","year":"2013","unstructured":"Dash, A. et al. Hemodynamic flow improves rat hepatocyte morphology, function, and metabolic activity in vitro. American journal of physiology. Cell physiology 304, C1053\u20131063, https:\/\/doi.org\/10.1152\/ajpcell.00331.2012 (2013).","journal-title":"Cell physiology"},{"key":"65817_CR40","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1177\/2211068214566939","volume":"20","author":"SR Khetani","year":"2015","unstructured":"Khetani, S. R. et al. Microengineered liver tissues for drug testing. Journal of laboratory automation 20, 216\u2013250, https:\/\/doi.org\/10.1177\/2211068214566939 (2015).","journal-title":"Journal of laboratory automation"},{"key":"65817_CR41","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/0143-4160(94)90073-6","volume":"16","author":"K Iizuka","year":"1994","unstructured":"Iizuka, K., Ikebe, M., Somlyo, A. V. & Somlyo, A. P. Introduction of high molecular weight (IgG) proteins into receptor coupled, permeabilized smooth muscle. Cell calcium 16, 431\u2013445 (1994).","journal-title":"Cell calcium"},{"key":"65817_CR42","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1111\/j.1600-6143.2004.00539.x","volume":"4","author":"WPD Lemahieu","year":"2004","unstructured":"Lemahieu, W. P. D., Maes, B. D., Verbeke, K. & Vanrenterghem, Y. CYP3A4 and P-glycoprotein activity in healthy controls and transplant patients on cyclosporin vs. tacrolimus vs. sirolimus. American Journal of Transplantation 4, 1514\u20131522 (2004).","journal-title":"American Journal of Transplantation"},{"key":"65817_CR43","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/00008571-200302000-00005","volume":"13","author":"B Chowbay","year":"2003","unstructured":"Chowbay, B., Cumaraswamy, S., Cheung, Y. B., Zhou, Q. & Lee, E. J. Genetic polymorphisms in MDR1 and CYP3A4 genes in Asians and the influence of MDR1 haplotypes on cyclosporin disposition in heart transplant recipients. Pharmacogenetics 13, 89\u201395 (2003).","journal-title":"Pharmacogenetics"},{"key":"65817_CR44","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1080\/00498250600861751","volume":"36","author":"K Bleasby","year":"2006","unstructured":"Bleasby, K. et al. Expression profiles of 50 xenobiotic transporter genes in humans and pre-clinical species: a resource for investigations into drug disposition. Xenobiotica; the fate of foreign compounds in biological systems 36, 963\u2013988, https:\/\/doi.org\/10.1080\/00498250600861751 (2006).","journal-title":"Xenobiotica; the fate of foreign compounds in biological systems"},{"key":"65817_CR45","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1517\/17425255.2013.741589","volume":"9","author":"X Chu","year":"2013","unstructured":"Chu, X., Bleasby, K. & Evers, R. Species differences in drug transporters and implications for translating preclinical findings to humans. Expert opinion on drug metabolism & toxicology 9, 237\u2013252 (2013).","journal-title":"Expert opinion on drug metabolism & toxicology"},{"key":"65817_CR46","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1517\/17425250903127234","volume":"5","author":"Y Lai","year":"2009","unstructured":"Lai, Y. Identification of interspecies difference in hepatobiliary transporters to improve extrapolation of human biliary secretion. Expert opinion on drug metabolism & toxicology 5, 1175\u20131187, https:\/\/doi.org\/10.1517\/17425250903127234 (2009).","journal-title":"Expert opinion on drug metabolism & toxicology"},{"key":"65817_CR47","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.vascn.2005.08.003","volume":"53","author":"AD Shilling","year":"2006","unstructured":"Shilling, A. D., Azam, F., Kao, J. & Leung, L. Use of canalicular membrane vesicles (CMVs) from rats, dogs, monkeys and humans to assess drug transport across the canalicular membrane. Journal of pharmacological and toxicological methods 53, 186\u2013197, https:\/\/doi.org\/10.1016\/j.vascn.2005.08.003 (2006).","journal-title":"Journal of pharmacological and toxicological methods"},{"key":"65817_CR48","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S0161-6420(13)31254-8","volume":"101","author":"AT Vitale","year":"1994","unstructured":"Vitale, A. T., Rodriguez, A. & Foster, C. S. Low-dose cyclosporine therapy in the treatment of birdshot retinochoroidopathy. Ophthalmology 101, 822\u2013831 (1994).","journal-title":"Ophthalmology"},{"key":"65817_CR49","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1681\/ASN.V124828","volume":"12","author":"K Mahalati","year":"2001","unstructured":"Mahalati, K. et al. Approaching the therapeutic window for cyclosporine in kidney transplantation: a prospective study. Journal of the American Society of Nephrology: JASN 12, 828\u2013833 (2001).","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"65817_CR50","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1681\/asn.2007121336","volume":"19","author":"AB Sanz","year":"2008","unstructured":"Sanz, A. B., Santamaria, B., Ruiz-Ortega, M., Egido, J. & Ortiz, A. Mechanisms of renal apoptosis in health and disease. Journal of the American Society of Nephrology: JASN 19, 1634\u20131642, https:\/\/doi.org\/10.1681\/asn.2007121336 (2008).","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"65817_CR51","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1046\/j.1523-1755.2000.00999.x","volume":"57","author":"A Amore","year":"2000","unstructured":"Amore, A. et al. Nitric oxide mediates cyclosporine-induced apoptosis in cultured renal cells. Kidney international 57, 1549\u20131559 (2000).","journal-title":"Kidney international"},{"key":"65817_CR52","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1093\/toxsci\/kfu153","volume":"142","author":"RA Clewell","year":"2014","unstructured":"Clewell, R. A. et al. Profiling dose-dependent activation of p53-mediated signaling pathways by chemicals with distinct mechanisms of DNA damage. Toxicological sciences: an official journal of the Society of Toxicology 142, 56\u201373, https:\/\/doi.org\/10.1093\/toxsci\/kfu153 (2014).","journal-title":"Toxicological sciences: an official journal of the Society of Toxicology"},{"key":"65817_CR53","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jprot.2012.11.022","volume":"79","author":"A Wilmes","year":"2013","unstructured":"Wilmes, A. et al. Application of integrated transcriptomic, proteomic and metabolomic profiling for the delineation of mechanisms of drug induced cell stress. Journal of Proteomics 79, 180\u2013194, https:\/\/doi.org\/10.1016\/j.jprot.2012.11.022 (2013).","journal-title":"Journal of Proteomics"},{"key":"65817_CR54","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1067\/mcp.2000.110561","volume":"68","author":"RA Branch","year":"2000","unstructured":"Branch, R. A., Adedoyin, A., Frye, R. F., Wilson, J. W. & Romkes, M. In vivo modulation of CYP enzymes by quinidine and rifampin. Clinical pharmacology and therapeutics 68, 401\u2013411, https:\/\/doi.org\/10.1067\/mcp.2000.110561 (2000).","journal-title":"Clinical pharmacology and therapeutics"},{"key":"65817_CR55","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s11095-006-0277-7","volume":"23","author":"JH Lin","year":"2006","unstructured":"Lin, J. H. CYP induction-mediated drug interactions: in vitro assessment and clinical implications. Pharmaceutical research 23, 1089\u20131116, https:\/\/doi.org\/10.1007\/s11095-006-0277-7 (2006).","journal-title":"Pharmaceutical research"},{"key":"65817_CR56","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1592\/phco.2005.25.6.779","volume":"25","author":"MS Joy","year":"2005","unstructured":"Joy, M. S., Nickeleit, V., Hogan, S. L., Thompson, B. D. & Finn, W. F. Calcineurin inhibitor-induced nephrotoxicity and renal expression of P-glycoprotein. Pharmacotherapy 25, 779\u2013789 (2005).","journal-title":"Pharmacotherapy"},{"key":"65817_CR57","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1038\/sj.ki.5000407","volume":"69","author":"M Huls","year":"2006","unstructured":"Huls, M., van den Heuvel, J. J., Dijkman, H. B., Russel, F. G. & Masereeuw, R. ABC transporter expression profiling after ischemic reperfusion injury in mouse kidney. Kidney international 69, 2186\u20132193, https:\/\/doi.org\/10.1038\/sj.ki.5000407 (2006).","journal-title":"Kidney international"},{"key":"65817_CR58","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s11481-006-9034-2","volume":"1","author":"D Pal","year":"2006","unstructured":"Pal, D. & Mitra, A. K. MDR- and CYP3A4-mediated drug-drug interactions. Journal of neuroimmune pharmacology: the official journal of the Society on NeuroImmune Pharmacology 1, 323\u2013339, https:\/\/doi.org\/10.1007\/s11481-006-9034-2 (2006).","journal-title":"Journal of neuroimmune pharmacology: the official journal of the Society on NeuroImmune Pharmacology"},{"key":"65817_CR59","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0378-4274(01)00306-X","volume":"120","author":"D Schrenk","year":"2001","unstructured":"Schrenk, D. et al. Up-regulation of transporters of the MRP family by drugs and toxins. Toxicology letters 120, 51\u201357 (2001).","journal-title":"Toxicology letters"},{"key":"65817_CR60","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/toxsci\/kft009","volume":"132","author":"S Schomaker","year":"2013","unstructured":"Schomaker, S. et al. Assessment of emerging biomarkers of liver injury in human subjects. Toxicological sciences: an official journal of the Society of Toxicology 132, 276\u2013283, https:\/\/doi.org\/10.1093\/toxsci\/kft009 (2013).","journal-title":"Toxicological sciences: an official journal of the Society of Toxicology"},{"key":"65817_CR61","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/toxsci\/kft221","volume":"137","author":"L Luo","year":"2014","unstructured":"Luo, L., Schomaker, S., Houle, C., Aubrecht, J. & Colangelo, J. L. Evaluation of serum bile acid profiles as biomarkers of liver injury in rodents. Toxicological sciences: an official journal of the Society of Toxicology 137, 12\u201325, https:\/\/doi.org\/10.1093\/toxsci\/kft221 (2014).","journal-title":"Toxicological sciences: an official journal of the Society of Toxicology"},{"key":"65817_CR62","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1080\/00365510802145059","volume":"241","author":"JV Bonventre","year":"2008","unstructured":"Bonventre, J. V. Kidney Injury Molecule-1 (KIM-1): a specific and sensitive biomarker of kidney injury. Scandinavian journal of clinical and laboratory investigation. Supplementum 241, 78\u201383, https:\/\/doi.org\/10.1080\/00365510802145059 (2008).","journal-title":"Supplementum"},{"key":"65817_CR63","doi-asserted-by":"publisher","first-page":"F1365","DOI":"10.1152\/ajprenal.90405.2008","volume":"295","author":"M Wieser","year":"2008","unstructured":"Wieser, M. et al. hTERT alone immortalizes epithelial cells of renal proximal tubules without changing their functional characteristics. American journal of physiology. Renal physiology 295, F1365\u20131375, https:\/\/doi.org\/10.1152\/ajprenal.90405.2008 (2008).","journal-title":"Renal physiology"},{"key":"65817_CR64","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.tiv.2014.10.005","volume":"30","author":"L Aschauer","year":"2015","unstructured":"Aschauer, L. et al. Application of RPTEC\/TERT1 cells for investigation of repeat dose nephrotoxicity: A transcriptomic study. Toxicology in vitro: an international journal published in association with BIBRA 30, 106\u2013116, https:\/\/doi.org\/10.1016\/j.tiv.2014.10.005 (2015).","journal-title":"Toxicology in vitro: an international journal published in association with BIBRA"},{"key":"65817_CR65","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.pharmthera.2012.09.004","volume":"137","author":"HG Xie","year":"2013","unstructured":"Xie, H. G., Wang, S. K., Cao, C. C. & Harpur, E. Qualified kidney biomarkers and their potential significance in drug safety evaluation and prediction. Pharmacology & therapeutics 137, 100\u2013107, https:\/\/doi.org\/10.1016\/j.pharmthera.2012.09.004 (2013).","journal-title":"Pharmacology & therapeutics"},{"key":"65817_CR66","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nbt0510-436","volume":"28","author":"JV Bonventre","year":"2010","unstructured":"Bonventre, J. V., Vaidya, V. S., Schmouder, R., Feig, P. & Dieterle, F. Next-generation biomarkers for detecting kidney toxicity. Nature biotechnology 28, 436\u2013440, https:\/\/doi.org\/10.1038\/nbt0510-436 (2010).","journal-title":"Nature biotechnology"},{"key":"65817_CR67","doi-asserted-by":"publisher","first-page":"6872149","DOI":"10.1155\/2016\/6872149","volume":"2016","author":"E Gacka","year":"2016","unstructured":"Gacka, E., Zyczkowski, M., Bogacki, R., Paradysz, A. & Hyla-Klekot, L. The Usefulness of Determining Neutrophil Gelatinase-Associated Lipocalin Concentration Excreted in the Urine in the Evaluation of Cyclosporine A Nephrotoxicity in Children with Nephrotic Syndrome. Disease markers 2016, 6872149, https:\/\/doi.org\/10.1155\/2016\/6872149 (2016).","journal-title":"Disease markers"},{"key":"65817_CR68","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/j.1440-1797.2010.01317.x","volume":"15","author":"P Devarajan","year":"2010","unstructured":"Devarajan, P. Review: neutrophil gelatinase-associated lipocalin: a troponin-like biomarker for human acute kidney injury. Nephrology (Carlton, Vic.) 15, 419\u2013428, https:\/\/doi.org\/10.1111\/j.1440-1797.2010.01317.x (2010).","journal-title":"Nephrology (Carlton, Vic.)"},{"key":"65817_CR69","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.tox.2010.08.013","volume":"277","author":"D Hoffmann","year":"2010","unstructured":"Hoffmann, D. et al. Evaluation of a urinary kidney biomarker panel in rat models of acute and subchronic nephrotoxicity. Toxicology 277, 49\u201358, https:\/\/doi.org\/10.1016\/j.tox.2010.08.013 (2010).","journal-title":"Toxicology"},{"key":"65817_CR70","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.toxlet.2012.12.015","volume":"217","author":"SJ Sohn","year":"2013","unstructured":"Sohn, S. J. et al. In vitro evaluation of biomarkers for cisplatin-induced nephrotoxicity using HK-2 human kidney epithelial cells. Toxicology letters 217, 235\u2013242, https:\/\/doi.org\/10.1016\/j.toxlet.2012.12.015 (2013).","journal-title":"Toxicology letters"},{"key":"65817_CR71","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.taap.2010.11.006","volume":"252","author":"KA Matheis","year":"2011","unstructured":"Matheis, K. A. et al. Cross-study and cross-omics comparisons of three nephrotoxic compounds reveal mechanistic insights and new candidate biomarkers. Toxicology and applied pharmacology 252, 112\u2013122, https:\/\/doi.org\/10.1016\/j.taap.2010.11.006 (2011).","journal-title":"Toxicology and applied pharmacology"},{"key":"65817_CR72","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1089\/ars.2012.4658","volume":"18","author":"MG Olsson","year":"2013","unstructured":"Olsson, M. G. et al. The radical-binding lipocalin A1M binds to a Complex I subunit and protects mitochondrial structure and function. Antioxidants & redox signaling 18, 2017\u20132028, https:\/\/doi.org\/10.1089\/ars.2012.4658 (2013).","journal-title":"Antioxidants & redox signaling"},{"issue":"Pt 3","key":"65817_CR73","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1042\/bj2730759","volume":"273","author":"RG Maatman","year":"1991","unstructured":"Maatman, R. G., Van Kuppevelt, T. H. & Veerkamp, J. H. Two types of fatty acid-binding protein in human kidney. Isolation, characterization and localization. The Biochemical journal 273(Pt 3), 759\u2013766 (1991).","journal-title":"The Biochemical journal"},{"key":"65817_CR74","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/ki.1993.19","volume":"43","author":"FN Ziyadeh","year":"1993","unstructured":"Ziyadeh, F. N. Renal tubular basement membrane and collagen type IV in diabetes mellitus. Kidney international 43, 114\u2013120 (1993).","journal-title":"Kidney international"},{"key":"65817_CR75","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.3349\/ymj.2004.45.6.1004","volume":"45","author":"C Li","year":"2004","unstructured":"Li, C., Lim, S. W., Sun, B. K. & Yang, C. W. Chronic cyclosporine nephrotoxicity: new insights and preventive strategies. Yonsei medical journal 45, 1004\u20131016, https:\/\/doi.org\/10.3349\/ymj.2004.45.6.1004 (2004).","journal-title":"Yonsei medical journal"},{"key":"65817_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-20340-1","volume":"8","author":"S Bauer","year":"2018","unstructured":"Bauer, S. et al. Publisher Correction: Functional coupling of human pancreatic islets and liver spheroids on-a-chip: Towards a novel human ex vivo type 2 diabetes model. Scientific reports 8, 1672, https:\/\/doi.org\/10.1038\/s41598-018-20340-1 (2018).","journal-title":"Scientific reports"},{"key":"65817_CR77","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s10544-007-9138-3","volume":"10","author":"MH Wu","year":"2008","unstructured":"Wu, M. H., Huang, S. B., Cui, Z., Cui, Z. & Lee, G. B. A high throughput perfusion-based microbioreactor platform integrated with pneumatic micropumps for three-dimensional cell culture. Biomedical microdevices 10, 309\u2013319, https:\/\/doi.org\/10.1007\/s10544-007-9138-3 (2008).","journal-title":"Biomedical microdevices"},{"key":"65817_CR78","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.snb.2007.07.145","volume":"129","author":"MH Wu","year":"2008","unstructured":"Wu, M. H., Huang, S. B., Cui, Z., Cui, Z. & Lee, G. B. Development of perfusion-based micro 3-D cell culture platform and its application for high throughput drug testing. Sensors & Actuators B Chemical 129, 231\u2013240 (2008).","journal-title":"Sensors & Actuators B Chemical"}],"updated-by":[{"DOI":"10.1038\/s41598-020-74148-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T00:00:00Z","timestamp":1602028800000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-65817-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-65817-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-65817-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T12:05:44Z","timestamp":1670328344000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-65817-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,1]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["65817"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-65817-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,1]]},"assertion":[{"value":"18 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An amendment to this paper has been published and can be accessed via a link at the top of the paper.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"U.M. is a shareholder and CEO of TissUse GmbH, Germany, which is commercializing the MOC platform. All other Authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8879"}}